Minimal change disease soon after Pfizer-BioNTech COVID-19 vaccination

We report on the onset of minimal change disease (MCD) presenting with anasarca after a second dose of the messenger RNA (mRNA)-based Pfizer-BioNTech vaccine against coronavirus disease 2019 (COVID-19). A 75-year-old previously healthy male was admitted with rapidly progressive anasarca and proteinu...

Descripción completa

Detalles Bibliográficos
Autores principales: Kobayashi, Seiji, Fugo, Kazunori, Yamazaki, Kazuto, Terawaki, Hiroyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Exceptional Case
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8499758/
https://www.ncbi.nlm.nih.gov/pubmed/34938534
http://dx.doi.org/10.1093/ckj/sfab156

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8499758/
https://www.ncbi.nlm.nih.gov/pubmed/34938534
http://dx.doi.org/10.1093/ckj/sfab156

Ejemplares similares